Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
AKR1C3 Antibody, 3-alpha-HSD type 2 Antibody, 17-beta-HSD 5 Antibody, 3-alpha-HSD type II, brain Antibody, DD3 Antibody, DDH1 Antibody, DDX Antibody, Dihydrodiol dehydrogenase 3 Antibody, Dihydrodiol dehydrogenase X Antibody, DD-3 Antibody, HA1753 Antibody, HAKRe Antibody, HAKRB Antibody, HSD17B5 Antibody, KIAA0119 Antibody, Kia0119 Antibody, Prostaglandin F synthase Antibody, PGFS Antibody, Truncated aldoketo reductase a Antibody, HluPGFS Antibody, Indanol dehydrogenase Antibody
DDX / AKR1C3 is a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2.